Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Nucleic Acid-based Therapeutics Companies

Nucleic acid-based therapeutics involve the use of genetic material, such as DNA or RNA, to treat or prevent diseases. These therapies can target specific genes or cellular processes, offering potential treatments for various medical conditions, including genetic disorders, cancers, and infectious diseases.

Nucleic Acid-based Therapeutics Key Companies

Latest Nucleic Acid-based Therapeutics Companies Update

Nov 2023Moderna (US) Received FDA approval for their second-generation COVID-19 booster vaccine (mRNA-1273.214) offering broader protection against circulating variants.Advanced clinical trials for their mRNA-based therapies for HIV, cytomegalovirus, and various types of cancer.

BioNTech (Germany) Partnered with Genmab to develop mRNA-based cancer vaccines targeting specific tumor antigens.Initiated Phase 1 trials for their mRNA therapy for Duchenne muscular dystrophy.

Alnylam Pharmaceuticals (US) Received FDA approval for their Onpattro® (patisiran) for the treatment of hereditary ATTR amyloidosis, expanding their RNAi therapy portfolio.Announced positive results from Phase 2a trials for their RNAi therapy for alpha-1 antitrypsin deficiency, a genetic liver disease.

Editas Medicine (US) Dosing of the first patient in their Phase 1/2 clinical trial for their CRISPR gene editing therapy for Leber congenital amaurosis, a genetic eye disease.Collaborated with Roche to develop CRISPR-based therapies for various rare genetic diseases.

Wave Life Sciences (US) Filed an IND application with the FDA for their mRNA therapy for Duchenne muscular dystrophy, entering the race for this promising market.Collaborated with Pfizer to develop mRNA-based therapies for rare neuromuscular diseases.

List of Nucleic Acid-based Therapeutics Key Companies in the Market

Wave Life Sciences Ltd

Copernicus Therapeutics Inc

Imugene

Caperna

Phylogica

Protagonist Therapeutics

Benitec Biopharma

EGEN (Expression Genetics)

Benitec Biopharma

BioMedica (Oxford BioMedica)

Transgene

Nucleic Acid-based Therapeutics Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.